Growth Metrics

Tandem Diabetes Care (TNDM) Revenue Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 16.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.08%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 15.05%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 7.41%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.29%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 5.46%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.46%
Dec 31, 2025 2.74%
Sep 30, 2025 2.17%
Jun 30, 2025 8.46%
Mar 31, 2025 22.30%
Dec 31, 2024 43.62%
Sep 30, 2024 31.43%
Jun 30, 2024 13.27%
Mar 31, 2024 13.16%
Dec 31, 2023 -10.75%
Sep 30, 2023 -9.25%
Jun 30, 2023 -2.17%
Mar 31, 2023 -3.71%
Dec 31, 2022 5.00%
Sep 30, 2022 13.87%
Jun 30, 2022 16.34%
Mar 31, 2022 24.72%
Dec 31, 2021 24.95%
Sep 30, 2021 45.33%
Jun 30, 2021 57.58%
Mar 31, 2021 44.02%
Dec 31, 2020 55.04%
Sep 30, 2020 30.58%
Jun 30, 2020 17.14%
Mar 31, 2020 48.38%
Dec 31, 2019 42.26%
Sep 30, 2019 104.60%
Jun 30, 2019 173.27%
Mar 31, 2019 141.94%
Dec 31, 2018 89.11%
Sep 30, 2018 71.33%
Jun 30, 2018 60.01%
Mar 31, 2018 43.74%
Dec 31, 2017 39.37%
Sep 30, 2017 119.66%
Jun 30, 2017 -7.21%
Mar 31, 2017 -5.39%
Dec 31, 2016 -0.71%
Sep 30, 2016 -21.78%
Jun 30, 2016 46.35%
Mar 31, 2016 62.97%
Dec 31, 2015 62.78%
Sep 30, 2015 16.30%
Jun 30, 2015 53.17%
Mar 31, 2015 52.59%
Dec 31, 2014 74.61%
Sep 30, 2014 73.78%
Jun 30, 2014 85.49%
Mar 31, 2014 47.78%